Table 1. Subject characteristics.
SUBJECT # | AGE (yrs) | RACE | SEX | CONDITION | PATHOGEN | ANALYSIS | PLATFORM |
3N | 6 | H | M | Control | Healthy | Training/Test | A |
5 | 10 | H | M | Osteomyelitis | MSSA | Training | A |
7N | 1.6 | B | F | Control | Healthy | Training/Test | A |
8N | 10 | B | M | Control | Healthy | Training/Test | A |
11N | 4 | B | F | Control | Healthy | Training/Test | A |
23N | 7 | H | F | Control | Healthy | Training/Test | A |
24 | 3 | B | M | Bacteremia, Osteomyelitis, Myositis | MRSA | Test | A |
24N | 3 | W | M | Control | Healthy | Training/Test | A |
30 | 15 | B | M | Bacteremia | MRSA | Test | A |
40 | 13 | W | M | Bacteremia, Osteomyelitis | MSSA | Training | A |
43 | 7 | B | M | Bacteremia, Osteomyelitis, SArthritis, Pyomyositis, Emboli | MRSA | Test | A |
62 | 2 | W | M | Osteomyelitis, Pyomyositis | MRSA | Training | A |
66 | 0.25 | B | F | Pneumonia | MRSA | Test | A |
67 | 7 | W | F | Bacteremia, Osteomyelitis | MRSA | Training | A |
88 | 0.92 | H | M | Bacteremia, Osteomyelitis, Pneumonia, Emboli | MRSA | Test | A |
90 | 0.67 | B | M | Bacteremia, SArthritis | MSSA | Test | A |
109 | 0.67 | H | F | Bacteremia, SST Abscess | MRSA | Training | A |
150 | 9 | B | F | Bacteremia, Osteomyelitis, SArthritis, Myositis | MRSA | Test | A |
179 | 12 | W | M | Bacteremia, Endocarditis, Emboli | MSSA | Training | A |
205 | 7 | H | M | Bacteremia, Pneumonia, SST Abscess | MRSA | Test | A |
208 | 10 | W | F | Bacteremia, Osteomyelitis, CNS abscess, Pneumonia, Emboli | MRSA | Test | A |
216 | 10 | H | F | Bacteremia, Osteomyelitis | MRSA | Training | A |
220 | 11 | H | M | Bacteremia, Osteomyelitis | MSSA | Test | A |
221 | 6 | B | F | Bacteremia, Osteomyelitis | MRSA | Training | A |
224 | 10 | W | M | Bacteremia, Osteomyelitis | MSSA | Test | A |
230 | 20 | B | M | Bacteremia, Endocarditis, SST Abscess | MRSA | Test | A |
241 | 0.92 | B | F | Bacteremia, Osteomyelitis, Pneumonia | MRSA | Training | A |
242 | 1.2 | B | M | Bacteremia, Osteomyelitis, Pyomyositis | MRSA | Test | A |
258 | 8 | W | F | Bacteremia, Osteomyelitis, Cellulitis | MSSA | Training | A |
262 | 13 | H | M | Bacteremia, SST Abscess | MRSA | Training | A |
264 | 13 | B | M | Bacteremia, Osteomyelitis, SArthritis, SST Abscess, Myositis, Emboli | MSSA | Test | A |
271 | 13 | B | M | Osteomyelitis, pyomyositis | MSSA | Training | A |
294 | 12 | B | F | Control | Healthy | Training/Test | A |
301 | 8 | W | M | Control | Healthy | Training/Test | A |
303 | 6 | W | F | Control | Healthy | Training/Test | A |
304 | 6 | W | M | Control | Healthy | Training/Test | A |
305 | 4 | H | F | Bacteremia, Osteomyelitis, SArthritis | MSSA | Training | A |
308 | 12 | B | F | Bacteremia, Pneumonia, Pyomyositis, SST Ab | MSSA | Training | A |
328 | 0.38 | B | F | Bacteremia, Osteomyelitis, Pneumonia, SST Abscess | MSSA | Test | A |
329 | 0.58 | O | F | Bacteremia, Lymphadenitis | MRSA | Training | A |
330 | 11 | B | F | Bacteremia, Pneumonia | MRSA | Test | A |
354 | 2 | H | F | Bacteremia, Osteomyelitis | MRSA | Training | A |
366 | 11 | B | F | Osteomyelitis, SST Abscess | MRSA | Test | A |
369 | 14 | B | M | Bacteremia, SArthritis, SST Abscess, Emboli | MRSA | Test | A |
372 | 14 | W | M | Bacteremia, Osteomyelitis, Myositis | MRSA | Test | A |
412 | 1.75 | W | M | Bacteremia, SArthritis | MSSA | Test | A |
418 | 8 | H | F | Osteomyelitis | MSSA | Training | A |
423 | 8 | W | M | Bacteremia, Osteomyelitis, Pyomyositis | MSSA | Training | A |
434 | 5 | W | M | Osteomyelitis, Pyomyositis | MSSA | Test | A |
440 | 0.5 | B | M | Bacteremia, Osteomyelitis, Pneumonia, Emboli | MRSA | Training | A |
450 | 0.83 | B | M | Bacteremia, Osteomyelitis, SArthritis, Pyomyositis | MSSA | Test | A |
451 | 4 | H | M | Bacteremia, Osteomyelitis, SArthritis, Pyomyositis, Emboli | MRSA | Training | A |
894 | 8 | W | F | Osteomyelitis, SST Abscess | MSSA | Validation, FACS | I |
903 | 13 | W | F | Control | Healthy | Validation, FACS | I |
904 | 16 | W | F | Control | Healthy | FACS | I |
905 | 16 | W | F | Control | Healthy | FACS | I |
907 | 1.3 | H | F | Bacteremia | MRSA | FACS | I |
908 | 8 | B | M | Bacteremia, Pleural effusion, Pyomyositis, SST Abscess, Emboli | MSSA | FACS | I |
909 | 6 | H | F | Bacteremia, Osteomyelitis, SArthritis, Pneumonia | MRSA | Validation, FACS | I |
910 | 5 | B | M | Osteomyelitis, SArthritis | MSSA | Validation, FACS | I |
922 | 3 | H | F | Control | Healthy | FACS | I |
926 | 3 | H | M | Control | Healthy | FACS | I |
927 | 2 | H | M | Control | Healthy | Validation, FACS | I |
929 | 11 | O | F | Control | Healthy | Validation, FACS | I |
930 | 8 | O | M | Control | Healthy | Validation | I |
931 | 12 | W | F | Control | Healthy | FACS | I |
933 | 9 | W | M | Control | Healthy | Validation, FACS | I |
935 | 9 | W | F | Control | Healthy | Validation, FACS | I |
939 | 8 | W | M | Control | Healthy | Validation, FACS | I |
940 | 7 | W | M | Control | Healthy | Validation, FACS | I |
941 | 9 | W | F | Control | Healthy | Validation, FACS | I |
943 | 9 | W | M | Osteomyelitis, SArthritis, Pyomyositis | MRSA | Validation, FACS | I |
944 | 6 | B | F | Bacteremia, Osteomyelitis, SArthritis, Pyomyositis | MRSA | Validation, FACS | I |
949 | 11 | W | M | Bacteremia, Osteomyelitis, SArthritis | MSSA | Validation | I |
952 | 15 | B | M | Bacteremia, Osteomyelitis, Pneumonia | MRSA | Validation, FACS | I |
954 | 13 | W | M | Bacteremia, Osteomyelitis, Pyomyositis | MSSA | Validation, FACS | I |
960 | 3 | H | M | Pneumonia | MRSA | Validation, FACS | I |
H = Hispanic, W = White, B = Black, O = Other; M = Male, F = Female; SST Ab = Skin/soft tissue abscess, SArthritis = Suppurative arthritis, CNS = central nervous system; MSSA = methicillin-susceptible Staphylococcus aureus, MRSA = methicillin-resistant Staphylococcus aureus; Platform: A = Affymetrix U133 A&B I = Illumina Sentrix Hu6 BeadChips.